文献速递神经核医学核素与放射性配体治疗

遗传性副神经节瘤-嗜铬细胞瘤综合征患者的多模态放射性核素显像

Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
PubMed 文献 · Clin Nucl Med · 2017-01-01

本文报告一例33岁女性遗传性副神经节瘤-嗜铬细胞瘤综合征患者,由SDHD肿瘤抑制基因突变所致。

要点

  • SDHD突变导致头颈部副神经节瘤和嗜铬细胞瘤易感。

核心结论

  • 不同显像模态对神经内分泌肿瘤的敏感性存在差异,并可能为多种靶向治疗提供依据。

研究设计与样本

  • 本文为病例报告,报告一例33岁女性遗传性副神经节瘤-嗜铬细胞瘤综合征患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hereditary paraganglioma (PGL)-pheochromocytoma (PCC) syndrome is a genetic disorder caused by a mutation of the tumor suppressor gene SDHD that results in a predisposition for head and neck PGLs and PCCs. We present a case of a 33-year-old woman where F-FDG PET/CT showed areas of increased uptake in both the adrenal and cervical regions, consistent with PCCs and PGLs, respectively. Further imaging revealed that PCCs were I-MIBG avid, whereas the PGLs were In-octreotide avid. This demonstrates the varying sensitivities of different imaging modalities in regard to neuroendocrine tumors and the potential for treatment using multiple targeted therapies.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yim SY, Moncayo VM, Pasquel FJ, et al. Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome. Clin Nucl Med. 2017. PMID: 28902732. doi:10.1097/RLU.0000000000001841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。